曼哈顿联合软件 MANH 深 沪
已收盘 04-02 16:00:00 美东时间
134.56
+0.260
+0.19%
华盛通- 最 高136.44
- 今 开134.06
- 成交量 44.91万股
- 最 低 130.57
- 昨 收 134.30
- 总市值 80.53亿
- 52周最高 247.22
- 市盈率 静 37.35
- 换手率 0.75%
- 52周最低 126.00
- 委 比 0.00%
- 总股本 5984.75万
- 历史最高 312.5999
- 量 比 0.96
- 振 幅 4.37%
- 历史最低 28.24
- 每 手 1
- 风险率 25.06%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多新浪财经ESG：曼哈顿联合软件 MSCI（明晟）ESG评级调降至A
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
03-24 10:25
Manhattan Associates benchmark finds 7% of specialty retailers are unified commerce leaders
Manhattan Associates benchmark finds 7% of specialty retailers are unified commerce leaders Manhattan Associates published findings from its 2026 Global Unified Commerce Benchmark for specialty retail, assessing more than 400 retailers across EMEA, LATAM, and North America on 330 capabilities. Only
03-23 20:30
美股大行评级 | 能源股获大行青睐！美国铝业、康索尔能源、康菲石油、EOG能源等获上调目标价；多只航空股遭下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Altimmune"买入"评级，目标价从12美元升至25美元；BTIG：维持Jade Biosciences"买入"评级，目标价从28美元升至39美元
03-17 11:45
Barclays Maintains Overweight on Manhattan Associates, Lowers Price Target to $236
Barclays analyst Guy Hardwick maintains Manhattan Associates (NASDAQ:MANH) with a Overweight and lowers the price target from $237 to $236.
03-16 23:24
U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Cogent Biosciences, Summit Therapeutics
U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Cogent Biosciences, Summit Therapeutics March 16 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Alnylam Pharmaceuticals, Cogent Biosciences and Summit Therapeutics on Monday
03-16 18:00
Rainforest Distribution selects Manhattan Active Supply Chain Planning from Manhattan Associates
Rainforest Distribution selects Manhattan Active Supply Chain Planning from Manhattan Associates Rainforest Distribution selected Manhattan Active Supply Chain Planning to unify its supply chain planning functions. The company said the platform will replace fragmented legacy tools and support demand
03-10 20:30
Manhattan Associates increases buyback program to $500M
Manhattan Associates (MANH) approved an increase in the company’s common share repurchase authority from $100M to $500M, effective immediately. More on Manhattan Associates Manhattan Associates, Inc. ...
03-05 21:43
Manhattan Associates Increases Buyback Plan To $500M
Manhattan Associates Inc. (NASDAQ: MANH) announced that its board of directors approved an increase in the company's common share repurchase authority from $100 million to $500 million, effective immediately.
03-05 21:36
BRIEF-Manhattan Associates Increases Share Repurchase Program To Us$500 Million
BRIEF-Manhattan Associates Increases Share Repurchase Program To Us$500 Million March 5 (Reuters) - Manhattan Associates Inc MANH.O : MANHATTAN ASSOCIATES INCREASES SHARE REPURCHASE PROGRAM TO US$500 MILLION Source text: ID:nBw1SFTfya Further company coverage: MANH.O (( Reuters.Briefs@thomsonreuters
03-05 21:32
Analysts Offer Insights on Technology Companies: Payoneer (PAYO), D-Wave Quantum (QBTS) and Manhattan Associates (MANH)
There’s a lot to be optimistic about in the Technology sector as 3 analysts jus...
02-27 03:20
